- Home
- CCCC vs DCGO Comparison
CCCC vs DCGO Comparison
Compare CCCC & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- DCGO
- Stock Information
- Founded
- CCCC 2015
- DCGO 2015
- Country
- CCCC United States
- DCGO United States
- Employees
- CCCC N/A
- DCGO N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- DCGO Managed Health Care
- Sector
- CCCC Health Care
- DCGO Health Care
- Exchange
- CCCC Nasdaq
- DCGO Nasdaq
- Market Cap
- CCCC 104.4M
- DCGO 138.7M
- IPO Year
- CCCC 2020
- DCGO N/A
- Fundamental
- Price
- CCCC $2.26
- DCGO $1.49
- Analyst Decision
- CCCC Buy
- DCGO Strong Buy
- Analyst Count
- CCCC 3
- DCGO 4
- Target Price
- CCCC $12.00
- DCGO $3.74
- AVG Volume (30 Days)
- CCCC 1.6M
- DCGO 729.3K
- Earning Date
- CCCC 07-31-2025
- DCGO 08-06-2025
- Dividend Yield
- CCCC N/A
- DCGO N/A
- EPS Growth
- CCCC N/A
- DCGO N/A
- EPS
- CCCC N/A
- DCGO N/A
- Revenue
- CCCC $39,783,000.00
- DCGO $520,500,658.00
- Revenue This Year
- CCCC N/A
- DCGO N/A
- Revenue Next Year
- CCCC N/A
- DCGO $4.08
- P/E Ratio
- CCCC N/A
- DCGO N/A
- Revenue Growth
- CCCC 98.56
- DCGO N/A
- 52 Week Low
- CCCC $1.09
- DCGO $1.23
- 52 Week High
- CCCC $7.66
- DCGO $5.68
- Technical
- Relative Strength Index (RSI)
- CCCC 63.62
- DCGO 45.38
- Support Level
- CCCC $1.36
- DCGO $1.50
- Resistance Level
- CCCC $2.17
- DCGO $1.62
- Average True Range (ATR)
- CCCC 0.15
- DCGO 0.09
- MACD
- CCCC 0.05
- DCGO 0.00
- Stochastic Oscillator
- CCCC 67.11
- DCGO 19.30
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.